Zobrazeno 1 - 10
of 32
pro vyhledávání: ''
Publikováno v:
Lasers in Medical Science; Apr2019, Vol. 34 Issue 3, p473-478, 6p
Autor:
Huang, Shengshi, Wang, Di, Zhang, Shu, Huang, Xiaoyan, Wang, Dandan, Ijaz, Muhammad, Shi, Yikang
Publikováno v:
Cancer Chemotherapy & Pharmacology; Oct2017, Vol. 80 Issue 4, p685-696, 12p
Autor:
Gibson, Rachel J., Keefe, Dorothy M.K., Thompson, Fiona M., Clarke, Julie M., Goland, Gary J., Cummins, Adrian G.
Publikováno v:
Digestive Diseases & Sciences; Dec2002, Vol. 47 Issue 12, p2751-2757, 7p, 3 Charts, 5 Graphs
Autor:
Soga, Shiro, Sharma, Sreenath V., Shiotsu, Yukimasa, Shimizu, Makiko, Tahara, Harunobu, Yamaguchi, Kazuo, Ikuina, Yoji, Murakata, Chikara, Tamaoki, Tatsuya, Kurebayashi, Junichi, Schulte, Theodor W., Neckers, Leonard M., Akinaga, Shiro, Soga, S, Sharma, S V, Shiotsu, Y, Shimizu, M, Tahara, H, Yamaguchi, K, Ikuina, Y
Publikováno v:
Cancer Chemotherapy & Pharmacology; Dec2001, Vol. 48 Issue 6, p435-445, 11p
Autor:
Koichi Kaneko, Heiji Yoshinaka, Takaaki Arigami, Sumiya Ishigami, Shinichi Ueno, Hiroshi Okumura, Shoji Natsugoe, Kazuhiro Tabata, Munetsugu Hirata, Yuko Kijima, Chihaya Koriyama, Akihiro Nakajo, Yoshiaki Shinden, Michiyo Higashi, Tadao Mizoguchi, Yoshikazu Uenosono, Hideo Arima, Kosei Maemura
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background The aim of this study was to investigate the maintenance of volume as a spacer by comparing vascular supply and apoptosis in an implanted autologous-free dermal fat graft (FDFG) and free fat graft (FFG). An autologous FDFG is a material us
Publikováno v:
Breast Cancer Research : BCR
Introduction Proteasome inhibition provides an attractive approach to cancer therapy and may have application in the treatment of breast cancer. However, results of recent clinical trials to evaluate the effect of the proteasome inhibitor Bortezomib
Publikováno v:
BMC Cancer
Background Although mammary microcalcification is frequently observed and has been associated with poor survival in patients with breast cancer, the genesis of calcification remains unclear. Carbonic anhydrase I (CA1) has been shown to promote calcif
Publikováno v:
Breast Cancer Research : BCR
Introduction New signaling pathways of the interleukin (IL) family, interferons (IFN) and interferon regulatory factors (IRF) have recently been found within tumor microenvironments and in metastatic sites. Some of these cytokines stimulate while oth
Publikováno v:
BMC Cancer
Background Breast cancer is one of the most deadly diseases in women. Inhibiting the synthesis of estrogen is effective in treating patients with estrogen-responsive breast cancer. Previous studies have demonstrated that use of cyclooxygenase (COX) i
Publikováno v:
Breast Cancer Research : BCR
Introduction Protein tyrosine kinase 6 (PTK6) is a non-receptor tyrosine kinase that is highly expressed in Human Epidermal Growth Factor 2+ (Her2+) breast cancers. Overexpression of PTK6 enhances anchorage-independent survival, proliferation, and mi